Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor

Figure 1

Serum creatinine and hepatitis C viral load before and after transplantation with a hepatitis C positive donor. The patient’s serum creatinine normalized without hemodialysis posttransplant and remains 1.6 mg/dL 12-month posttransplant. Hepatitis C viremia was detected on postoperative day 3 with glecaprevir/pibrentasvir treatment initiated on postoperative day 9. Hepatitis C viremia was undetectable by 1-month posttransplant and has remained undetectable at 12-month posttransplant. TPE: therapeutic plasma exchange; POD: postoperative day. ^⧫Activated for hepatitis C positive offers. ^▲Initiation of glecaprevir/pibrentasvir.